Tafamidis Is Associated With Higher Risk Of New Atrial Fibrillation And Lower Risk Of Death In Patients With Transthyretin Amyloid Cardiomyopathy: An Exploratory Analysis From Real World Experience

Journal of Cardiac Failure 2026

View at publisher

Authors: Tessa M. Zeis, Bryan Q. Abadie, Mazen A Hanna, Wael A. Jaber

DOI: 10.1016/j.cardfail.2025.11.421

Cited by: 0

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Atrial Fibrillation Management and Outcomes Cardiac electrophysiology and arrhythmias